Cecolin 9 is indicated for females aged 9–45 years.

For diseases caused by HPV types 16 and 18, Cecolin 9 is indicated to help prevent cervical cancer cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3), adenocarcinoma in situ (AIS), and cervical intraepithelial neoplasia grade 1 (CIN1).¹

In the published Phase 3 HPV-PRO-009 study, Cecolin 9 demonstrated 98.2% vaccine efficacy against ≥12-month persistent infection associated with HPV6/11/31/33/45/52/58. Evaluation of high-grade genital lesions associated with HPV31/33/45/52/58 and genital warts related to HPV6/11 is ongoing.⁷

Important Things to Know

Cecolin 9 is a preventive vaccine. It:

• does not treat existing HPV infection or other HPV-related disease.
• does not protect against HPV types not included in the vaccine.
• may not protect every person who receives it.
• does not replace routine cervical cancer screening.

HPV vaccination works best when given before exposure to HPV. Please talk to a healthcare professional about whether Cecolin 9 is appropriate for you or your child.^1,6,8